Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The miR-183 Cluster: Biogenesis, Functions, and Cell Communication via Exosomes in Cancer. | Cells | 2023 | 37174715 | PubTator, text mining | PubMed |
| The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives. | Cancers (Basel) | 2023 | 37174062 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease. | Clin Transl Immunology | 2023 | 37144041 | PubTator, text mining | PubMed |
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | Front Immunol | 2023 | 37143664 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target. | Clin Lymphoma Myeloma Leuk | 2023 | 37142534 | PubTator, text mining | PubMed |
| Low RNA stability signifies increased post-transcriptional regulation of cell identity genes. | Nucleic Acids Res | 2023 | 37125636 | PubTator, text mining | PubMed |
| The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines. | Viruses | 2023 | 37113007 | PubTator, text mining | PubMed |
| Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians. | Immun Inflamm Dis | 2023 | 37102642 | PubTator, text mining | PubMed |
| Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cells. | Cell Rep | 2023 | 37099427 | PubTator, text mining | PubMed |
| Degrading the signal amplifier: ITK as a target for targeted protein degradation. | Cell Chem Biol | 2023 | 37084715 | PubTator, text mining | PubMed |
| Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. | Nat Commun | 2023 | 37080976 | PubTator, text mining | PubMed |
| COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 | 37072858 | PubTator, text mining | PubMed |
| ITK signaling regulates a switch between T helper 17 and T regulatory cell lineages via a calcium-mediated pathway. | bioRxiv | 2023 | 37066370 | PubTator, text mining | PubMed |
| CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer. | Front Immunol | 2023 | 37063862 | PubTator, text mining | PubMed |
| Bruton tyrosine kinase inhibitors for multiple sclerosis. | Nat Rev Neurol | 2023 | 37055617 | PubTator, text mining | PubMed |
| A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. | Cell Death Discov | 2023 | 37055391 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals in vivo osteoimmunology interactions between the immune and skeletal systems. | Front Endocrinol (Lausanne) | 2023 | 37051201 | PubTator, text mining | PubMed |
| Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia. | J Clin Med | 2023 | 37048814 | PubTator, text mining | PubMed |
| Comparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus. | J Clin Med | 2023 | 37048724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=17